410 related articles for article (PubMed ID: 22955318)
1. Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension.
Savai R; Pullamsetti SS; Kolbe J; Bieniek E; Voswinckel R; Fink L; Scheed A; Ritter C; Dahal BK; Vater A; Klussmann S; Ghofrani HA; Weissmann N; Klepetko W; Banat GA; Seeger W; Grimminger F; Schermuly RT
Am J Respir Crit Care Med; 2012 Nov; 186(9):897-908. PubMed ID: 22955318
[TBL] [Abstract][Full Text] [Related]
2. Phosphodiesterase 1 upregulation in pulmonary arterial hypertension: target for reverse-remodeling therapy.
Schermuly RT; Pullamsetti SS; Kwapiszewska G; Dumitrascu R; Tian X; Weissmann N; Ghofrani HA; Kaulen C; Dunkern T; Schudt C; Voswinckel R; Zhou J; Samidurai A; Klepetko W; Paddenberg R; Kummer W; Seeger W; Grimminger F
Circulation; 2007 May; 115(17):2331-9. PubMed ID: 17438150
[TBL] [Abstract][Full Text] [Related]
3. Syngeneic bone marrow mononuclear cells improve pulmonary arterial hypertension through vascular endothelial growth factor upregulation.
Yoshida H; Kitaichi T; Urata M; Kurobe H; Kanbara T; Motoki T; Kitagawa T
Ann Thorac Surg; 2009 Aug; 88(2):418-24. PubMed ID: 19632386
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cell recruitment in lesions of human and experimental pulmonary hypertension.
Perros F; Dorfmüller P; Souza R; Durand-Gasselin I; Mussot S; Mazmanian M; Hervé P; Emilie D; Simonneau G; Humbert M
Eur Respir J; 2007 Mar; 29(3):462-8. PubMed ID: 17107989
[TBL] [Abstract][Full Text] [Related]
5. C-kit-positive cells accumulate in remodeled vessels of idiopathic pulmonary arterial hypertension.
Montani D; Perros F; Gambaryan N; Girerd B; Dorfmuller P; Price LC; Huertas A; Hammad H; Lambrecht B; Simonneau G; Launay JM; Cohen-Kaminsky S; Humbert M
Am J Respir Crit Care Med; 2011 Jul; 184(1):116-23. PubMed ID: 21471108
[TBL] [Abstract][Full Text] [Related]
6. Diverse contribution of bone marrow-derived cells to vascular remodeling associated with pulmonary arterial hypertension and arterial neointimal formation.
Sahara M; Sata M; Morita T; Nakamura K; Hirata Y; Nagai R
Circulation; 2007 Jan; 115(4):509-17. PubMed ID: 17242277
[TBL] [Abstract][Full Text] [Related]
7. Amlodipine prevents monocrotaline-induced pulmonary arterial hypertension and prolongs survival in rats independent of blood pressure lowering.
Mawatari E; Hongo M; Sakai A; Terasawa F; Takahashi M; Yazaki Y; Kinoshita O; Ikeda U
Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):594-600. PubMed ID: 17581214
[TBL] [Abstract][Full Text] [Related]
8. Combined effects of the ATP-sensitive potassium channel opener pinacidil and simvastatin on pulmonary vascular remodeling in rats with monocrotaline-induced pulmonary arterial hypertension.
Jiang L; Zhou T; Liu H
Pharmazie; 2012 Jun; 67(6):547-52. PubMed ID: 22822545
[TBL] [Abstract][Full Text] [Related]
9. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease.
Zhao YD; Courtman DW; Deng Y; Kugathasan L; Zhang Q; Stewart DJ
Circ Res; 2005 Mar; 96(4):442-50. PubMed ID: 15692087
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary lymphoid neogenesis in idiopathic pulmonary arterial hypertension.
Perros F; Dorfmüller P; Montani D; Hammad H; Waelput W; Girerd B; Raymond N; Mercier O; Mussot S; Cohen-Kaminsky S; Humbert M; Lambrecht BN
Am J Respir Crit Care Med; 2012 Feb; 185(3):311-21. PubMed ID: 22108206
[TBL] [Abstract][Full Text] [Related]
11. Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases.
Dorfmüller P; Humbert M; Perros F; Sanchez O; Simonneau G; Müller KM; Capron F
Hum Pathol; 2007 Jun; 38(6):893-902. PubMed ID: 17376507
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of the IL-13 receptor system: a novel pathomechanism in pulmonary arterial hypertension.
Hecker M; Zaslona Z; Kwapiszewska G; Niess G; Zakrzewicz A; Hergenreider E; Wilhelm J; Marsh LM; Sedding D; Klepetko W; Lohmeyer J; Dimmeler S; Seeger W; Weissmann N; Schermuly RT; Kneidinger N; Eickelberg O; Morty RE
Am J Respir Crit Care Med; 2010 Sep; 182(6):805-18. PubMed ID: 20522789
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of Human Endogenous Retrovirus-K Is Linked to Immunity and Inflammation in Pulmonary Arterial Hypertension.
Saito T; Miyagawa K; Chen SY; Tamosiuniene R; Wang L; Sharpe O; Samayoa E; Harada D; Moonen JAJ; Cao A; Chen PI; Hennigs JK; Gu M; Li CG; Leib RD; Li D; Adams CM; Del Rosario PA; Bill M; Haddad F; Montoya JG; Robinson WH; Fantl WJ; Nolan GP; Zamanian RT; Nicolls MR; Chiu CY; Ariza ME; Rabinovitch M
Circulation; 2017 Nov; 136(20):1920-1935. PubMed ID: 28935667
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticle-mediated delivery of nuclear factor kappaB decoy into lungs ameliorates monocrotaline-induced pulmonary arterial hypertension.
Kimura S; Egashira K; Chen L; Nakano K; Iwata E; Miyagawa M; Tsujimoto H; Hara K; Morishita R; Sueishi K; Tominaga R; Sunagawa K
Hypertension; 2009 May; 53(5):877-83. PubMed ID: 19307469
[TBL] [Abstract][Full Text] [Related]
15. CPU 86017, p-chlorobenzyltetrahydroberberine chloride, attenuates monocrotaline-induced pulmonary hypertension by suppressing endothelin pathway.
Zhang TT; Cui B; Dai DZ; Su W
Acta Pharmacol Sin; 2005 Nov; 26(11):1309-16. PubMed ID: 16225752
[TBL] [Abstract][Full Text] [Related]
16. Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension.
Zakrzewicz A; Hecker M; Marsh LM; Kwapiszewska G; Nejman B; Long L; Seeger W; Schermuly RT; Morrell NW; Morty RE; Eickelberg O
Circulation; 2007 Jun; 115(23):2957-68. PubMed ID: 17515463
[TBL] [Abstract][Full Text] [Related]
17. [Administrating bone marrow mesenchymal stem cells to treat the experimental pulmonary arterial hypertension in rats].
He ZX; Wang HW; Shang F; Yan H; Yang Y
Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(30):2110-5. PubMed ID: 20058614
[TBL] [Abstract][Full Text] [Related]
18. Increased oxidative stress and severe arterial remodeling induced by permanent high-flow challenge in experimental pulmonary hypertension.
Dorfmüller P; Chaumais MC; Giannakouli M; Durand-Gasselin I; Raymond N; Fadel E; Mercier O; Charlotte F; Montani D; Simonneau G; Humbert M; Perros F
Respir Res; 2011 Sep; 12(1):119. PubMed ID: 21906276
[TBL] [Abstract][Full Text] [Related]
19. Inhaled tolafentrine reverses pulmonary vascular remodeling via inhibition of smooth muscle cell migration.
Pullamsetti S; Krick S; Yilmaz H; Ghofrani HA; Schudt C; Weissmann N; Fuchs B; Seeger W; Grimminger F; Schermuly RT
Respir Res; 2005 Nov; 6(1):128. PubMed ID: 16262900
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical examination of plexiform-like complex vascular lesions in the lungs of broiler chickens selected for susceptibility to idiopathic pulmonary arterial hypertension.
Hamal KR; Erf GF; Anthony NB; Wideman RF
Avian Pathol; 2012; 41(2):211-9. PubMed ID: 22515539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
